IKT vs ELPW Comparison

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

Elong Power Holding Ltd is engaged in research and development, manufacturing, sales, and service of high-power lithium-ion batteries for electric vehicles and construction machinery, as well as large-capacity, long-cycle lithium-ion batteries for energy storage systems. The company's lower-cost, high-power, and fast-charging batteries are designed specifically for commercial vehicles and specialty vehicles that require large-capacity energy storage systems. It operates in one operating segment and includes the manufacture, commercialization, and distribution of a variety of battery cells and battery packs for use in a wide array of applications.